Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors
July 26, 2019 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments
June 27, 2019 16:05 ET | Avid Bioservices, Inc
 -- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146% Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- ...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices To Report Financial Results For Third Quarter Of Fiscal Year 2019 After Market Close On March 11, 2019
March 04, 2019 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2019 and Recent Developments
December 10, 2018 16:05 ET | Avid Bioservices, Inc
-- Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Signed Project Expansion Orders for $6.3 Million with Current Customers -- -- Successfully Executed Scheduled Broad Scale...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
December 05, 2018 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2019 After Market Close on December 10, 2018
December 03, 2018 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Exhibit at the 17th Annual Contracting & Outsourcing Conference
September 20, 2018 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments
September 10, 2018 16:05 ET | Avid Bioservices, Inc
-- Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Multiple Projects Advanced During the Quarter -- -- Initiated Operations of New Process Development Laboratories -- TUSTIN,...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
September 05, 2018 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Present at Upcoming Investor Conferences
August 29, 2018 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...